ELIQUIS - Articles and news items

Blood clot deep vein thrombosis Venous thromboembolism pulmonary embolism

Venous thromboembolism (VTE) therapeutics market set to hit $3.7 billion by 2025

Industry news / 1 August 2016 / GlobalData

Growth will be driven by the uptake of novel oral anticoagulants, which represent important advances over warfarin, a cheap and established anticoagulant, says new report…

Pfizer logo

ELIQUIS® (apixaban) receives positive opinion from CHMP

Industry news, News / 24 September 2012 / Pfizer

For the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation…

Bristol Myers Squibb logo

Bristol-Myers Squibb & Pfizer receive response from FDA for ELIQUIS® (apixaban)

Industry news, News / 26 June 2012 / Bristol-Myers Squibb Company / Pfizer

Additional information requested from ARISTOTLE trial results…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...